{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T18:16:25Z","timestamp":1778264185642,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T00:00:00Z","timestamp":1575590400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T00:00:00Z","timestamp":1575590400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s00277-019-03867-9","type":"journal-article","created":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T04:53:35Z","timestamp":1575608015000},"page":"83-91","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prognostic significance of FDG-PET\/CT in determining upfront autologous stem cell transplantation for the treatment of peripheral T cell lymphomas"],"prefix":"10.1007","volume":"99","author":[{"given":"Seo-Yeon","family":"Ahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Yeon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Hoon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Sook","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Je-Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeoung-Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sae-Ryung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeon-Hee","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Yong","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho-Young","family":"Yhim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deok-Hwan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,6]]},"reference":[{"key":"3867_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","volume":"107","author":"LM Morton","year":"2006","unstructured":"Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS (2006) Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 107:265\u2013276. https:\/\/doi.org\/10.1182\/blood-2005-06-2508","journal-title":"Blood"},{"key":"3867_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/oxfordjournals.annonc.a057673","volume":"1","author":"B Coiffier","year":"1990","unstructured":"Coiffier B, Brousse N, Peuchmaur M, Berger F, Gisselbrecht C, Bryon PA, Diebold J (1990) Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d'Etude des Lymphomes Agressives). Ann Oncol 1:45\u201350. https:\/\/doi.org\/10.1093\/oxfordjournals.annonc.a057673","journal-title":"Ann Oncol"},{"key":"3867_CR3","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"Vose J, Armitage J, Weisenburger D, International TCLP","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D, International TCLP (2008) International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26:4124\u20134130. https:\/\/doi.org\/10.1200\/JCO.2008.16.4558","journal-title":"J Clin Oncol"},{"key":"3867_CR4","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1182\/blood.V93.11.3913","volume":"93","author":"RD Gascoyne","year":"1999","unstructured":"Gascoyne RD, Aoun P, Wu D, Chhanabhai M, Skinnider BF, Greiner TC, Morris SW, Connors JM, Vose JM, Viswanatha DS, Coldman A, Weisenburger DD (1999) Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood 93:3913\u20133921","journal-title":"Blood"},{"key":"3867_CR5","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/sj.leu.2404306","volume":"20","author":"P Corradini","year":"2006","unstructured":"Corradini P, Tarella C, Zallio F, Dodero A, Zanni M, Valagussa P, Gianni AM, Rambaldi A, Barbui T, Cortelazzo S (2006) Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation. Leukemia 20:1533\u20131538. https:\/\/doi.org\/10.1038\/sj.leu.2404306","journal-title":"Leukemia"},{"key":"3867_CR6","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1093\/annonc\/mdn022","volume":"19","author":"S Mercadal","year":"2008","unstructured":"Mercadal S, Briones J, Xicoy B, Pedro C, Escoda L, Estany C, Camos M, Colomo L, Espinosa I, Martinez S, Ribera JM, Martino R, Gutierrez-Garcia G, Montserrat E, Lopez-Guillermo A, Grup per l'Estudi dels Limfomes de Catalunya IB (2008) Intensive chemotherapy (high-dose CHOP\/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma. Ann Oncol 19:958\u2013963. https:\/\/doi.org\/10.1093\/annonc\/mdn022","journal-title":"Ann Oncol"},{"key":"3867_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1600-0609.2007.00856.x","volume":"79","author":"J Rodriguez","year":"2007","unstructured":"Rodriguez J, Conde E, Gutierrez A, Arranz R, Leon A, Marin J, Bendandi M, Albo C, Caballero MD, Grupo Espanol de Linfomas\/Trasplante Autologo de Medula O (2007) Frontline autologous stem cell transplantation in high-risk peripheral T-cell lymphoma: a prospective study from The Gel-Tamo Study Group. Eur J Haematol 79:32\u201338. https:\/\/doi.org\/10.1111\/j.1600-0609.2007.00856.x","journal-title":"Eur J Haematol"},{"key":"3867_CR8","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1200\/JCO.2011.40.2719","volume":"30","author":"F d'Amore","year":"2012","unstructured":"d'Amore F, Relander T, Lauritzsen GF, Jantunen E, Hagberg H, Anderson H, Holte H, Osterborg A, Merup M, Brown P, Kuittinen O, Erlanson M, Ostenstad B, Fagerli UM, Gadeberg OV, Sundstrom C, Delabie J, Ralfkiaer E, Vornanen M, Toldbod HE (2012) Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01. J Clin Oncol 30:3093\u20133099. https:\/\/doi.org\/10.1200\/JCO.2011.40.2719","journal-title":"J Clin Oncol"},{"key":"3867_CR9","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","volume":"103","author":"A Gallamini","year":"2004","unstructured":"Gallamini A, Stelitano C, Calvi R, Bellei M, Mattei D, Vitolo U, Morabito F, Martelli M, Brusamolino E, Iannitto E, Zaja F, Cortelazzo S, Rigacci L, Devizzi L, Todeschini G, Santini G, Brugiatelli M, Federico M, Intergruppo Italiano L (2004) Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood 103:2474\u20132479. https:\/\/doi.org\/10.1182\/blood-2003-09-3080","journal-title":"Blood"},{"key":"3867_CR10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/annonc\/mdq359","volume":"22","author":"G Gutierrez-Garcia","year":"2011","unstructured":"Gutierrez-Garcia G, Garcia-Herrera A, Cardesa T, Martinez A, Villamor N, Ghita G, Martinez-Trillos A, Colomo L, Setoain X, Rodriguez S, Gine E, Campo E, Lopez-Guillermo A (2011) Comparison of four prognostic scores in peripheral T-cell lymphoma. Ann Oncol 22:397\u2013404. https:\/\/doi.org\/10.1093\/annonc\/mdq359","journal-title":"Ann Oncol"},{"key":"3867_CR11","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1200\/jco.2007.11.6525","volume":"25","author":"A Gallamini","year":"2007","unstructured":"Gallamini A, Hutchings M, Rigacci L, Specht L, Merli F, Hansen M, Patti C, Loft A, Di Raimondo F, D'Amore F, Biggi A, Vitolo U, Stelitano C, Sancetta R, Trentin L, Luminari S, Iannitto E, Viviani S, Pierri I, Levis A (2007) Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study. J Clin Oncol 25:3746\u20133752. https:\/\/doi.org\/10.1200\/jco.2007.11.6525","journal-title":"J Clin Oncol"},{"key":"3867_CR12","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.ejca.2010.12.027","volume":"47","author":"DH Yang","year":"2011","unstructured":"Yang DH, Min JJ, Song HC, Jeong YY, Chung WK, Bae SY, Ahn JS, Kim YK, Bom HS, Chung IJ, Kim HJ, Lee JJ (2011) Prognostic significance of interim (1)(8)F-FDG PET\/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma. Eur J Cancer 47:1312\u20131318. https:\/\/doi.org\/10.1016\/j.ejca.2010.12.027","journal-title":"Eur J Cancer"},{"key":"3867_CR13","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1093\/annonc\/mdi272","volume":"16","author":"NG Mikhaeel","year":"2005","unstructured":"Mikhaeel NG, Hutchings M, Fields PA, O\u2019Doherty MJ, Timothy AR (2005) FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma. Ann Oncol 16:1514\u20131523. https:\/\/doi.org\/10.1093\/annonc\/mdi272","journal-title":"Ann Oncol"},{"key":"3867_CR14","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA, Alliance AL, Lymphoma G, Eastern Cooperative Oncology G, European Mantle Cell Lymphoma C, Italian Lymphoma F, European Organisation for R, Treatment of Cancer\/Dutch Hemato-Oncology G, Grupo Espanol de Medula O, German High-Grade Lymphoma Study G, German Hodgkin\u2019s Study G, Japanese Lymphorra Study G, Lymphoma Study A, Group NCT, Nordic Lymphoma Study G, Southwest Oncology G, United Kingdom National Cancer Research I (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32:3059\u20133068. https:\/\/doi.org\/10.1200\/JCO.2013.54.8800","journal-title":"J Clin Oncol"},{"key":"3867_CR15","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/ajh.24128","volume":"90","author":"TC El-Galaly","year":"2015","unstructured":"El-Galaly TC, Pedersen MB, Hutchings M, Mylam KJ, Madsen J, Gang AO, Bogsted M, de Nully BP, Loft A, Nielsen AL, Hendel HW, Iyer V, Gormsen LC (2015) Utility of interim and end-of-treatment PET\/CT in peripheral T-cell lymphomas: a review of 124 patients. Am J Hematol 90:975\u2013980. https:\/\/doi.org\/10.1002\/ajh.24128","journal-title":"Am J Hematol"},{"key":"3867_CR16","doi-asserted-by":"publisher","first-page":"e395","DOI":"10.1038\/bcj.2016.2","volume":"6","author":"JS Ham","year":"2016","unstructured":"Ham JS, Kim SJ, Choi JY, Hyun SH, Choi SK, Kim HS, Lim SH, Lee JY, Jung SH, Ko YH, Kim WS (2016) The prognostic value of interim and end-of-treatment PET\/CT in patients with newly diagnosed peripheral T-cell lymphoma. Blood Cancer J 6:e395. https:\/\/doi.org\/10.1038\/bcj.2016.2","journal-title":"Blood Cancer J"},{"key":"3867_CR17","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00277-014-2227-5","volume":"94","author":"N Tomita","year":"2015","unstructured":"Tomita N, Hattori Y, Fujisawa S, Hashimoto C, Taguchi J, Takasaki H, Sakai R, Tateishi U, Ishigatsubo Y (2015) Post-therapy (1)(8)F-fluorodeoxyglucose positron emission tomography for predicting outcome in patients with peripheral T cell lymphoma. Ann Hematol 94:431\u2013436. https:\/\/doi.org\/10.1007\/s00277-014-2227-5","journal-title":"Ann Hematol"},{"key":"3867_CR18","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1634\/theoncologist.2013-0463","volume":"19","author":"C Pellegrini","year":"2014","unstructured":"Pellegrini C, Argnani L, Broccoli A, Stefoni V, Derenzini E, Gandolfi L, Casadei B, Maglie R, Pileri S, Zinzani PL (2014) Prognostic value of interim positron emission tomography in patients with peripheral T-cell lymphoma. Oncologist 19:746\u2013750. https:\/\/doi.org\/10.1634\/theoncologist.2013-0463","journal-title":"Oncologist"},{"key":"3867_CR19","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12885-015-1193-1","volume":"15","author":"SH Jung","year":"2015","unstructured":"Jung SH, Ahn JS, Kim YK, Kweon SS, Min JJ, Bom HS, Kim HJ, Chae YS, Moon JH, Sohn SK, Lee SW, Byun BH, Do YR, Lee JJ, Yang DH (2015) Prognostic significance of interim PET\/CT based on visual, SUV-based, and MTV-based assessment in the treatment of peripheral T-cell lymphoma. BMC Cancer 15:198. https:\/\/doi.org\/10.1186\/s12885-015-1193-1","journal-title":"BMC Cancer"},{"key":"3867_CR20","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00277-013-1685-5","volume":"92","author":"JS Ahn","year":"2013","unstructured":"Ahn JS, Yang DH, Jung SH, Chae YS, Sohn SK, Yhim HY, Kwak JY, Lee SR, Kim YK, Kim HJ, Lee JJ (2013) Autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide as an intensifying frontline treatment in patients with peripheral T cell lymphomas: a multicenter retrospective trial. Ann Hematol 92:789\u2013797. https:\/\/doi.org\/10.1007\/s00277-013-1685-5","journal-title":"Ann Hematol"},{"key":"3867_CR21","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1080\/10428190903040048","volume":"50","author":"M Meignan","year":"2009","unstructured":"Meignan M, Gallamini A, Meignan M, Gallamini A, Haioun C (2009) Report on the first international workshop on interim-PET-scan in lymphoma. Leuk Lymphoma 50:1257\u20131260. https:\/\/doi.org\/10.1080\/10428190903040048","journal-title":"Leuk Lymphoma"},{"key":"3867_CR22","first-page":"482","volume":"91","author":"M Hutchings","year":"2006","unstructured":"Hutchings M, Loft A, Hansen M, Pedersen LM, Berthelsen AK, Keiding S, D'Amore F, Boesen AM, Roemer L, Specht L (2006) Position emission tomography with or without computed tomography in the primary staging of Hodgkin\u2019s lymphoma. Haematologica 91:482\u2013489","journal-title":"Haematologica"},{"key":"3867_CR23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1148\/radiol.2015142088","volume":"276","author":"SA Johnson","year":"2015","unstructured":"Johnson SA, Kumar A, Matasar MJ, Schoder H, Rademaker J (2015) Imaging for staging and response assessment in lymphoma. Radiology 276:323\u2013338. https:\/\/doi.org\/10.1148\/radiol.2015142088","journal-title":"Radiology"},{"key":"3867_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2016.63","volume":"6","author":"M Wilhelm","year":"2016","unstructured":"Wilhelm M, Smetak M, Reimer P, Geissinger E, Ruediger T, Metzner B, Schmitz N, Engert A, Schaefer-Eckart K, Birkmann J (2016) First-line therapy of peripheral T-cell lymphoma: extension and long-term follow-up of a study investigating the role of autologous stem cell transplantation. Blood Cancer J 6:e452. https:\/\/doi.org\/10.1038\/bcj.2016.63","journal-title":"Blood Cancer J"},{"key":"3867_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0121822","volume":"10","author":"G Gritti","year":"2015","unstructured":"Gritti G, Boschini C, Rossi A, Delaini F, Grassi A, Algarotti A, Mico C, Trezzi R, Gianatti A, Barbui AM, Rambaldi A (2015) Primary treatment response rather than front line stem cell transplantation is crucial for long term outcome of peripheral T-cell lymphomas. PLoS One 10:e0121822. https:\/\/doi.org\/10.1371\/journal.pone.0121822","journal-title":"PLoS One"},{"key":"3867_CR26","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1007\/s00259-018-4093-1","volume":"45","author":"HY Yhim","year":"2018","unstructured":"Yhim HY, Park Y, Han YH, Kim S, Kang SR, Moon JH, Jeong JH, Shin HJ, Kim K, Choi YS, Kim K, Kim MK, Kong E, Kim DS, Eo JS, Lee JH, Kang DY, Lee WS, Lee SM, Do YR, Ham JS, Kim SJ, Kim WS, Choi JY, Yang DH, Kwak JY (2018) A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score. Eur J Nucl Med Mol Imaging 45:2274\u20132284. https:\/\/doi.org\/10.1007\/s00259-018-4093-1","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3867_CR27","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1016\/S2352-3026(15)00002-2","volume":"2","author":"SJ Kim","year":"2015","unstructured":"Kim SJ, Choi JY, Hyun SH, Ki CS, Oh D, Ahn YC, Ko YH, Choi S, Jung SH, Khong PL, Tang T, Yan X, Lim ST, Kwong YL, Kim WS, Asia Lymphoma Study G (2015) Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer\/T-cell lymphoma, nasal type: a multicentre, retrospective analysis. Lancet Haematol 2:e66\u2013e74. https:\/\/doi.org\/10.1016\/S2352-3026(15)00002-2","journal-title":"Lancet Haematol"},{"key":"3867_CR28","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2967\/jnumed.112.110890","volume":"54","author":"A Biggi","year":"2013","unstructured":"Biggi A, Gallamini A, Chauvie S, Hutchings M, Kostakoglu L, Gregianin M, Meignan M, Malkowski B, Hofman MS, Barrington SF (2013) International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma: interpretation criteria and concordance rate among reviewers. J Nucl Med 54:683\u2013690. https:\/\/doi.org\/10.2967\/jnumed.112.110890","journal-title":"J Nucl Med"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03867-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-019-03867-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03867-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T00:19:44Z","timestamp":1607127584000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-019-03867-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,6]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["3867"],"URL":"https:\/\/doi.org\/10.1007\/s00277-019-03867-9","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,6]]},"assertion":[{"value":"18 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}